Pathways in physiological and pathological hypertrophy of the heart. Largely based on the article from [https://www.ncbi.nlm.nih.gov/pubmed/11714087 Wang et al, 'Signal transduction in cardiac hypertrophy--dissecting compensatory versus pathological pathways utilizing a transgenic approach.]
Hypertrohpy of the heart can be a physiological compensation for exercise, but it can also be a pathological compensation for hypertension and stress.
Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP1528 CPTAC Assay Portal]a6dca4a68e1aed4be1c5fe83ebdefde1ab2bad7e83b12d0aa29ad7e8310528039PubMedSignaling pathways for cardiac hypertrophy and failure.N Engl J Med1999Hunter JJChien KRhypertrophic cardiomyopathyDOID:11984Disease8621626PubMedCardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways.J Biol Chem1996Wollert KCTaga TSaito MNarazaki MKishimoto TGlembotski CCVernallis ABHeath JKPennica DWood WIChien KR10086361PubMedCalcineurin and human heart failure.Nat Med1999Lim HWMolkentin JD9253712PubMedCardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development.J Mol Med1997Wollert KCChien KRcardiac muscle cellCL:0000746Cell Type10952417PubMedAdvances in the molecular mechanisms of heart failure.Curr Opin Cardiol2000MacLellan WR11055975PubMedCalcineurin and beyond: cardiac hypertrophic signaling.Circ Res2000Molkentin JD10189350PubMedPrevention of cardiac hypertrophy by calcineurin inhibition: hope or hype?Circ Res1999Olson ENMolkentin JD10864911PubMedTransgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy.Circ Res2000Takeishi YPing PBolli RKirkpatrick DLHoit BDWalsh RA16936699PubMedRegulation of cardiac hypertrophy by intracellular signalling pathways.Nat Rev Mol Cell Biol2006Heineke JMolkentin JDheart diseaseDOID:114Disease9568714PubMedA calcineurin-dependent transcriptional pathway for cardiac hypertrophy.Cell1998Molkentin JDLu JRAntos CLMarkham BRichardson JRobbins JGrant SROlson EN10615383PubMedSignal transduction during cardiac hypertrophy: the role of G alpha q, PLC beta I, and PKC.Cardiovasc Res1999Jalili TTakeishi YWalsh RA11714087PubMedSignal transduction in cardiac hypertrophy--dissecting compensatory versus pathological pathways utilizing a transgenic approach.Curr Opin Pharmacol2001Wang Y9488659PubMedCardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells.J Biol Chem1998Wang YSu BSah VPBrown JHHan JChien KRhypertrophic cardiomyopathy pathwayPW:0000296Pathway Ontology10827130PubMedSmall guanine nucleotide-binding proteins and myocardial hypertrophy.Circ Res2000Clerk ASugden PH11101507PubMedThe MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice.EMBO J2000Bueno OFDe Windt LJTymitz KMWitt SAKimball TRKlevitsky RHewett TEJones SPLefer DJPeng CFKitsis RNMolkentin JD